# A Pharmacokinetic Evaluation Study in Healthy Volunteers

> **NCT00210093** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** denufosol tetrasodium (INS37217)

## Key facts

- **NCT ID:** NCT00210093
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2003-05
- **Final completion:** 2003-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00210093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00210093, "A Pharmacokinetic Evaluation Study in Healthy Volunteers". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00210093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*